Neurology Specific Literature Search   
 
[home][thesaurus]
    

Enter your terms
above and click
the 'Search' button.
Showing articles 0 to 50 of 126 Next >>

Filter Applied: review article (Click to remove)

Lyme Disease: What the Neuroradiologist Needs to Know
AJNR 40:1998-2000, Valand, H.A.,et al, 2019

Cogan Syndrome
www.medlink.com, Feb, Ramachandran, T.S., 2010

Lyme Neuroborreliosis: Manifestations of a Rapidly Emerging Zoonosis
AJNR 30:1079-1087, Hildenbrand,P.,et al, 2009

Dermatomyositis
Lancet 355:53-57, Callen,J.P., 2000

Neurologic Aspects of Inflammatory Bowel Disease
Neurol 45:416-421, Lossos,A.,et al, 1995

Eye Movement Abnormalities in Systemic Lupus Erythematosus
Arch Neurol 52:1145-1149, Keane,J.R., 1995

The Clinical Spectrum of the Eosinophilia-Myalgia Syndrome Associated with L-Tryptophan Ingestion
Ann Int Med 113:124-134, Martin,R.W.,et al, 1990

Magnetic Resonance Imaging of Head & Neck
Presenting Status & Future Potential, Council on Scientific Affairs, Panel on MRI, JAMA 260:3313-332, , 1988, 1988

Cogan's Syndrome:18 Cases & a Review of the Literature
Mayo Clin Proc 61:344-361, Vollertsen,R.S.,et al, 1986

Inflammatory Myopathies
Ann Neurol 17:215-227, 317-3231985., Mastaglia,F.L.,et al, 1985

Idiopathic Inflammatory Orbital Pseudotumor in Childhood
Ophthalmology 88:565-574, Mottow-Lippa,L., et al, 1981

Diagnosis and Management of ANCA-Associated Vasculitis
Lancet 403:683-698, Kronbichler, A., et al, 2024

Cavernous Sinus Thrombosis
StatPearls PMID:28846357, Plewa,M.C.,et al, 2023

Epidemiology, Survival, and Clinical Characteristics of Inclusion Body Myositis
Ann Neurol 92:201-212, Lindgren, U.,et al, 2022

The Tolosa-Hunt Syndrome
NJJP 71:577-582, Kline,L.B. & Hoyt,W.F., 2021

Blurred Vision
BMJ 368:m569, Zhou, S.,et al, 2020

Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020

When the Temporal Artery Biopsy is Negative
Neurologist 25:70-72, Ford, E. & Smith, J.H., 2020

Neurologic Complications of Coronavirus Infections
Neurol 94:809-810, Nath, A., 2020

Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020

COVID-19: A Global Threat to the Nervous System
Ann Neurol 88:1-11, Koralnik, I.J. & Tyler, K.L., 2020

Neuromuscular Adverse Events Associated with Anti-PD-1 Monoclonal Antibodies
Neurol 92:663-674, Johansen, A.,et al, 2019

Metabolic Lipid Muscle Disorders: Biomarkers and Treatment
Ther Adv Neurol Disord 12:1-15, Angelini, C.,et al, 2019

Behcet Disease
emedicine.medscape.com Dec, Davey-Ranasinghe, N. & Diamond, H.S., 2018

Migraine
NEJM 377:553-561, Charles, A., 2017

Neuromyelitis Optica Spectrum Disorders
UpToDate, May, Glisson,C.C., 2016

Neurological, Respiratory, Musculoskeletal, Cardiac and Ocular Side-Effects of Anti-PD-1 Therapy
Eur J Cancer 60:210-225, Zimmer, L.,et al, 2016

Inflammatory Muscle Diseases
NEJM 372:1734-1747, Dalakas, M.C., 2015

Cavernous Sinus Thrombosis in Children
Stroke 46:2657-2660, Press, C.A.,et al, 2015

Giant-Cell Arteritis and Polymyalgia Rheumatica
NEJM 371:50-57, Weyand, C.M. & Goronzy J.J., 2014

Infections of the Nervous System, (Bacterial, Fungal, Spirochetal, Parasitic) and Sarcoidosis, Mycoplasma Pneumoniae
Adams & Victors Principles of Neurology, Chp 32, pg 708, Ropper, A.H.,et al, 2014

Paraneoplastic Neurological Syndromes
Clin Exp Immunol 175:336-348, Leypoldt, F. & Wandinger, K.-P., 2014

Correlation of Clinicoserologic and Pathologic Classifications of Inflammatory Myopathies
Medicine 92:15-24, Fernandez, C.,et al, 2013

Polymyalgia Rheumatica
Lancet 381:63-72, Kermani, T. & Washington, K., 2013

Cogan Syndrome An Analysis of Reported Neurological Manifestations
The Neurologist 18:55-63, Antonios,N. and Silliman,S., 2012

Cluster Headache
BMJ 344:e2407, Nesbitt,A.D.,et al, 2012

Heterogeneity of Coenzyme Q10 Deficiency
Arch Neurol 69:978-983, Emmanuele, V.,et al, 2012

Infectious Mononucleosis in Adults and Adolescents
UpToDate, May, Aronson,M.D. & Auwaerter,P.G., 2011

Carbon Monoxide Poisoning
NEJM 360:1217-1225, Weaver,L.K., 2009

Toxic and Drug-Induced Myopathies
JNNP 80:832-838, Dalakas,M.C., 2009

Evaluation and Treatment of Inflammatory Myopathies
JNNP 80:1060-1068, Amato,A. &Barohn,R.J., 2009

Polymyalgia Rheumatica
BMJ 336:765-769, Michet,C.J. &Matteson,E.L., 2008

Polymyalgia Rheumatica and Giant-Cell Arteritis
Lancet 372:234-245, Salvarani,C.,et al., 2008

Juvenile Dermatomyositis and Other Idiopathic Inflammatory Myopathies of Childhood
Lancet 371:2201-2212, Feldman,B.M.,et al., 2008

Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008

Statin Induced Myopathy
BMJ 337:1159-1162, Sathasivam,S. &Lecky,B., 2008

Whipples Disease
NEJM 356:55-66, Fenollar,F.,et al, 2007

The Role of Muscle Biopsy in Investigating Isolated Muscle Pain
Neurol 68:181-186,170, Filosto,M.,et al, 2007

Cavernous Sinus Syndrome: A Series of 126 Patients
Medicine 86:278-281, Fern�ndez,S.,et al, 2007



Showing articles 0 to 50 of 126 Next >>